Burning Rock Biotech Limited announced that the underwriters of its initial public offering fully exercised their over-allotment option to purchase an additional 2,025,000 American Depositary Shares, each representing one Class A ordinary share, of the Company at the IPO price of US$16.50 per ADS.
June 22, 2020
· 2 min read